IDLogiq provides Global 5000 companies with highly secure, FIPS-compliant, state of the art cryptographic products and services to combat counterfeiting. In addition to anti-counterfeiting, we also provide a powerful yet easy to use communication and engagement platform to empower the supply chain to connect with consumers. This platform enables extra services such as product recalls and customer feedback.
IDLogiq also provides Healthcare Providers (HCP) with services and technology to monitor disease and symptom progression remotely and then engage with acute and chronically ill patients virtually to modify care plans and to provide education on self-care, based on changes in the patient’s condition. In addition, we provide patients with medication management and education so that they can adhere to care plans prescribed by Health Providers to achieve a holistic health management.
Our leadership consists of entrepreneurs with proven track records of successful exits in high-tech, pharmaceutical, and medical industry.
IDLogiq team consists of healthcare and technology professionals who envision the integration of mobile, cloud service, and IoMT (Internet of Medical Things) technology is the key to the future of healthcare ecosystem. We believe that health and wellness is a continuous engagement among all members of the health ecosystem, which includes patients, healthcare providers, payers, with the patient being the center of care. There are certain services that will continue to require patient to be inside the clinical environment; however, with advances in IoMT we envision that patients can be continuously cared for, from anywhere, all the time, for a better quality of life, without being confined to clinical environment.
We envision a healthy world free of counterfeit drugs, electronics, clothing, and much more with a global environment working together to optimize business efficiency and safety, while also providing valuable insight, optimized business intelligence, and detailed consumer spending habits directly from each industry.
Dr. Kelly Nguyen, Pharm.D.
Co-founder / CEODr. Nguyen is an experienced entrepreneur and executive with a proven track record. Prior to IDLogiq, Dr. Nguyen was the CoFounder/CEO of Mission Road Pharmacy, a specialty pharmacy with an annualized revenue of $160M+ and growing at more than 200% annually prior to getting acquired in 2012. Dr. Nguyen holds 2 granted and 4 pending patents in the field of Telehealth/Digital Health, Blockchain, and Cryptographic Anti-counterfeit technology, and a Doctor degree in Pharmaceuticals from the University of California, San Francisco.
Cofounder / President & CTO
Duc Pham is the co-founder and President/CTO IDLogiq, responsible for all technical aspects of the product and operation.
Pham is an entrepreneur and thought leader in the cryptography/data encryption and cybersecurity space for more than 20 years. Prior to IDLogiq, he was the founder and CTO of Vormetric (acquired by Thales for $400 million in 2015), a leader in information security company. Under his leadership, the Vormetric engineering team developed the most advanced enterprise-class, cross-platform information security protection system that can protect the data core even when the whole network and several other system components are compromised. Thanks to the architecture and unique inventions, Vormetric became the leader in enterprise information security technology, integrating encryption, access control, audit, and host integrity protection to provide a secure computing environment for high-profile clients in the financial and banking sectors as well as the US federal government. Pham also led and won major OEM agreements with IBM (Database Encryption Expert) and Symantec (Media Server Encryption Option).
Prior to Vormetric, Pham was the founder and CEO of Linux4 Networks, a leader in SSL encryption acceleration technology (acquired by Avaya in 2001), which achieved 160 times performance of a high-end CPU with a single cryptographic accelerator module, resulting in humongous 16,000% TCO (Total Cost of Ownership) savings in system management, software licensing, power, hardware, network infrastructure, etc.
Pham has extensive experience in corporate strategy with proven track record for product development, data security operations, enterprise software, electronic payment networks, mission-critical storage systems, and consumer and mobile computing. He invented the Vormetric data encryption technology.
Pham has 11 granted and 20 pending patents in the field of Cybersecurity/Data Encryption, Securing Messaging, Parallel Processing, Consumer/Mobile Computing, and Loyalty systems.
Co-Founder / VP Business Development
Mr. Steven Phung is an accomplished senior information technology manager with business and customer focused health care experience in managing large enterprise infrastructure and organization, medical, energy, retail, and non-profit sector. Extensive in-depth experience leading operations for Technology, Business Development, and Application Development. Possesses experience with government and civil contracts, development of Statement of Work (SOW), proposal development, competitive bidding and negotiations. Track record of successful project management and leadership: Health Information Technology, data center consolidation, vendor negotiations, outsourcing, and reorganizations.
Co-Founder / CTO of VT Design & Specialties. Inc., an innovative, visionary design technical solutions company with multi-disciplinary, multi-cultural teams unite providing a wealth of expertise, experience and know-how to leverage technology, in today's ever-changing, fast-paced and challenging environments.
Prior to DrKumo, Mr. Phung was the Director of Information Technology of Los Angeles County where he managed an IT Department of 260 staff members that supports an organization of 14,000 people at multiple locations and overseeing the entire technology infrastructure and decision making; managed a data center and network infrastructure assets in support of enterprise business applications (HIT) Health Information Technology systems that meet the security scrutiny from HIPAA and Federal standards for the Medical and Educational Entities; developed IT Policies and standardized IT procedures and protocols that exceeds the California State Audit Standards.
Mr. Kiem Le is an entrepreneur and a true visionary with over 40 years of experience in engineering, manufacturing and leadership. He is the Founder and CEO of Quality Systems Integrated Corporation (QSIC), a global, full-fledged, leading electronics manufacturing services company established in 1994, which develops unique solutions and upholds the highest degree of quality and excellence, agility and flexibility that enable 100% On-Time Delivery of Defect-free Products.
QSIC is DrKumo’s US-based manufacturing arm of medical devices. QSIC’s core competencies in electronics manufacturing, engineering, value-added services, supply chain management, and testing services are designed to meet customers’ unique requirements and production schedule. QSIC serves a variety of industries including but not limited to: healthcare/medical, military/defense, aerospace, space technologies, telecommunications, wireless, renewable energy, consumer commercial, and computer networking.
QSIC holds ISO 9001:2015, ISO 13845:2016, AS9100 Rev D, ANSI/ESD S20.20 certifications, and NADCAP AC 7120 accreditation, which govern its procedures at Quality Systems. All products built to Class III, IPC-A-610/620 standards and will be functional, ICT, or flying probe tested at the client’s request. Quality Systems certifications and standard practices include:
- IITAR Registered
- On-site IPC-A-610/620 and J-STD-001GS (Revision G – Space) Instructors
- Certified IPC A 620 inspectors
- Certified IPC-A-610/620 and J-STD 001GS inspectors and operators
- 5S Lean Six Sigma Black Belts and Green Belts
Mr. Le is also the Founder of CenterComm Corporation and co-Founder at Stracon Incorporated. Prior to QSIC and DrKumo, he also worked for Linkabit Corporation (Founders of Qualcomm) – M/A-Com Linkabit – Titan Linkabit, satellite equipment provider, from 1981 to 1993. He began as an Electrical Design Engineers and quickly rose to the position of Director of Engineering. His steadfast leadership over the years paved way for greater productivity and more convenient service delivery.
Mr. Le holds a Bachelor of Science with Honors (B. Sc Hons) in Electrical Engineering as well as a Master of Science (M. Sc) in Electrical Engineering from San Diego State University. Mr. Le equally holds patents in GPS technology.
Mr. Bill Schroeder, or Mr. William J Schroeder, a highly regarded technology industry executive and sought after advisory member in Silicon Valley and beyond. His substantial experience building and taking companies public makes him a valuable addition as we take IDLogiq to the next level of development.
Mr. Schroeder has grown tech companies from start-up through IPO and led three large successful IPO’s (Diamond Multimedia, Conner Peripherals, and Priam). He has served as the president and/or CEO of high tech companies in Silicon Valley, also served on the boards of those companies, as well as an outside board member with several other companies and helped guide several companies to successful IPOs and acquisitions, including Nimble Storage (IPO 2013 with $1.5B valuation, acquired by HP) , Con-way (acquired by XPO Logistics for $3B), Vormetric (acquired by Thales Group for $400M), Oxford Semiconductor (acquired by PLX Technology), WatchGuard Technologies (IPO, acquired by Francisco Partners), AlphaSmart (IPO, acquired by Renaissance Learning), Omneon (acquired by Harmonic) , Xircom (IPO, acquired by Intel for $748M), and VXtreme (acquired by Microsoft).
Prior to working in Silicon Valley, Mr. Schroeder worked for McKinsey & Company as a consultant. Schroeder holds the BSEE and MSEE from Marquette University and the MBA with High Distinction from Harvard Business School.
Dr. Jack Bui, MD/PhD
Dr. Jack Bui, MD/PhD, is board-certified in Clinical Pathology and serves as Director of the UCSD Stem Cell Processing Laboratory and Flow Cytometry and Immunology Laboratory. His core research interest is in understanding immune recognition of uninfected, stress or damaged tissues, such as tumor cells and transplantable normal cells. His basic research uses both mouse models of cancer and samples from cancer patients. He has expertise in the immunophenotyping of immune subsets and in particular participates in multiple clinical trials where patient samples are analyzed for immune cell numbers and activity.
Dr. Bui received his PhD in 1999 working on T cell memory at UCSD in Steve Hedrick’s Lab. He received his MD in 2001 at UCSD and then entered a research residency program at Washington University. He worked with Robert Schreiber studying how innate cells and T-regulatory cells influence tumor formation.
Dr. Jeffrey Glenn, MD/PhD
Dr. Jeffrey Glenn, M.D., Ph.D. is a Professor of Medicine (Division of Gastroenterology & Hepatology) and Microbiology & Immunology at Stanford University School of Medicine, and the Director of the Center for Hepatitis and Liver Tissue Engineering. He also heads a research laboratory focused on studying molecular virology and the translation of that knowledge into novel antiviral strategies, as well as the development of new treatments for liver diseases and cancer. He is the founder of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), co-founder of Riboscience LLC, and founder of I-Cubed Therapeutics, biotechnology companies developing several new classes of antiviral and anti-cancer drugs.
Dr. Glenn was born in Los Angeles, and grew up in Switzerland. He received his B.A. degree in Biochemistry and French Civilization from U.C. Berkeley from where he graduated summa cum laude. He received his M.D. and Ph.D. in Biochemistry and Biophysics from U.C.S.F.. He trained in internal medicine at Stanford University where he completed specialty training in gastroenterology, and joined the faculty in 2000.
He is the principal investigator on multiple NIH grants, an inventor on numerous patents, an elected member of the American Society for Clinical Investigation, and a member of the FDA Antiviral Drugs Advisory Committee.
Dr. David Masiello, MD
Dr. David Masiello is a Hematology Oncology Specialist in Los Angeles, California and is affiliated with multiple hospitals in the area, including Community Memorial Hospital, Desert Regional Medical Center, Foothill Presbyterian Hospital, Keck Medical Center Of USC, San Dimas Community Hospital, St John’s Regional Medical Center, White Memorial Medical Center and White Memorial Medical Center.
Dr. Masiello received his Bachelors of Science in Biochemistry and Molecular Biology from the University of Chicago. He attended medical school at Boston University School of medicine. After medical school, he completed his internship year and residency in internal medicine at the Boston City Hospital. He then moved to Los Angeles completing a fellowship in Hematology/Oncology at University of Southern California/LAC+USC. Trained in oncologic and hematologic malignancies as well as hematological disorders, Dr. Masiello shares a special interest in leukemia.
Mr. Kazufuku Nitta is an inventor and pioneer in medical High Frequency Oscillatory (HFO) ventilation market. He is the founder of Metran Co., Ltd. and invented the first HFO ventilator for premature neonates in 1984. He has been at the forefront of ventilatory technology by developing new and unique products that meet the various clinical needs of customers worldwide. As a result of his leadership and personal involvement in research and development for over 30 years, Metran have successfully launched multiple easy-to-use products with very sophisticated functions using unique technology and became the leader in HFO market with the very best of Japanese technology and quality to deliver products that people can trust.
Thanks to his inventions, High Frequency Oscillatory ventilators have helped save thousands of lives of premature babies or patients recovering from life-threatening situations, and for that great cause, his company received an Honorable Imperial Visit by The Emperor of Japan. He hopes to continue to put the needs of children, their parents and loved ones first and to continue to deliver these products throughout the world.